145 related articles for article (PubMed ID: 25464880)
21. Resistance to linezolid caused by modifications at its binding site on the ribosome.
Long KS; Vester B
Antimicrob Agents Chemother; 2012 Feb; 56(2):603-12. PubMed ID: 22143525
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
Liu J; He B; Yu A; Zhou W
Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antibacterial activities of eperezolid analogs with glycinyl substitutions.
Wang XJ; Wu N; Du GJ; Zhao SQ; Yan M; Gu LQ
Arch Pharm (Weinheim); 2009 Jul; 342(7):377-85. PubMed ID: 19544480
[TBL] [Abstract][Full Text] [Related]
24. Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics.
Ding D; Boudreau MA; Leemans E; Spink E; Yamaguchi T; Testero SA; O'Daniel PI; Lastochkin E; Chang M; Mobashery S
Bioorg Med Chem Lett; 2015 Nov; 25(21):4854-4857. PubMed ID: 26144346
[TBL] [Abstract][Full Text] [Related]
25. New oxazolidinones.
Vara Prasad JV
Curr Opin Microbiol; 2007 Oct; 10(5):454-60. PubMed ID: 17928263
[TBL] [Abstract][Full Text] [Related]
26. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
Bioorg Med Chem Lett; 2008 Dec; 18(23):6175-8. PubMed ID: 18947996
[TBL] [Abstract][Full Text] [Related]
27. Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones.
Quiles-Melero I; García-Perea A; de Pablos M; Gómez-Gil R; Mingorance J
Int J Med Microbiol; 2012 Jul; 302(3):145-7. PubMed ID: 22578666
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials.
Johnson PD; Aristoff PA; Zurenko GE; Schaadt RD; Yagi BH; Ford CW; Hamel JC; Stapert D; Moerman JK
Bioorg Med Chem Lett; 2003 Dec; 13(23):4197-200. PubMed ID: 14623000
[TBL] [Abstract][Full Text] [Related]
29. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S
Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
[TBL] [Abstract][Full Text] [Related]
30. The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.
Thomasco LM; Gadwood RC; Weaver EA; Ochoada JM; Ford CW; Zurenko GE; Hamel JC; Stapert D; Moerman JK; Schaadt RD; Yagi BH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4193-6. PubMed ID: 14622999
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M
BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents.
Xin Q; Fan H; Guo B; He H; Gao S; Wang H; Huang Y; Yang Y
J Med Chem; 2011 Nov; 54(21):7493-502. PubMed ID: 21955296
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel benzoxazinyl-oxazolidinones as potential antibacterial agents.
Guo B; Fan H; Xin Q; Chu W; Wang H; Yang Y
Bioorg Med Chem Lett; 2013 Jul; 23(13):3697-9. PubMed ID: 23721807
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
Bhattarai D; Lee SH; Seo SH; Nam G; Kang SB; Pae AN; Kim EE; Oh T; Cho SN; Keum G
Chem Biol Drug Des; 2012 Sep; 80(3):388-97. PubMed ID: 22553981
[TBL] [Abstract][Full Text] [Related]
35. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
36. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
38. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
Ross JE; Fritsche TR; Sader HS; Jones RN
Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
40. Oxazolidinone structure-activity relationships leading to linezolid.
Barbachyn MR; Ford CW
Angew Chem Int Ed Engl; 2003 May; 42(18):2010-23. PubMed ID: 12746812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
